Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PAIN MANAGEMENT PARTNERS LLC

NPI: 1306485925 · WATERBURY, CT 06708 · Pain Medicine (Anesthesiology) Physician · NPI assigned 12/30/2019

$39.18
Total Medicaid Paid
15,988
Total Claims
15,074
Beneficiaries
20
Codes Billed
2020-04
First Month
2024-11
Last Month

Provider Details

Authorized OfficialSPRAGUE, ELIZABETH (PRACTICE MANAGER)
NPI Enumeration Date12/30/2019

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 2,711 $0.00
2021 5,783 $0.00
2022 5,712 $39.18
2023 1,106 $0.00
2024 676 $0.00

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 11,797 11,014 $39.18
96138 539 532 $0.00
96130 539 532 $0.00
G0444 Annual depression screening, 5 to 15 minutes 271 268 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 67 65 $0.00
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 213 201 $0.00
99490 Ccm add 20min 49 49 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 92 91 $0.00
64495 31 26 $0.00
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 14 12 $0.00
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes 541 534 $0.00
64494 90 78 $0.00
96132 539 532 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 14 13 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 356 340 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 238 219 $0.00
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 360 339 $0.00
64493 80 78 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 104 100 $0.00
64483 54 51 $0.00